A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
This report contains market size and forecasts of Pharmaceutical CDMO Services in Global, including the following market information:
Global Pharmaceutical CDMO Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutical CDMO Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Substance Development and Manufacturing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical CDMO Services include Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, Catalent, Inc., Amatsigroup, WuXi AppTec Group, Strides Pharma Science Limited and Piramal Pharma Solutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical CDMO Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical CDMO Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, by Type, 2021 (%)
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
Global Pharmaceutical CDMO Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, by Application, 2021 (%)
Innovative Medicine
Patented Drug
Patent Expired Drug
Global Pharmaceutical CDMO Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical CDMO Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutical CDMO Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services